- Bupa Platinum consultant
-
Fee assured
-
Awaiting
verification
- Open Referral network
Specialises in
- Colon
- Hepatobiliary
- Lower GI
- Upper GI
Offers
- Face-to-face consultations
- Video and telephone consultations
- Home chemotherapy
About me
Dr Daniel Krell qualified in medicine at Leeds University Medical School, where he also gained a Bachelor’s degree in microbiology and immunology. He completed his junior doctor training at Guys and St. Thomas’ Hospitals and University College Hospital before undertaking his oncology training at The Royal Free and University College Hospitals in London.
Dr Krell’s DPhil research was undertaken at Oxford University, at the Wellcome Trust Centre for Human Genetics, and was funded by Cancer Research UK and HCA. Dr Krell’s research investigated the role that genetic mutations in genes controlling cellular metabolism play in the development of cancer, with the aim of identifying new therapeutic targets in this area. He continues to be involved in clinical research and clinical trials aimed at identifying new cancer therapies, with a focus on gastrointestinal and hepatobiliary malignancies. He also maintains an interest in cancer genetics and genetic testing for hereditary gastrointestinal cancers, with a particular focus on hereditary colorectal cancer.
Dr Krell has published several peer-reviewed papers in journals such as the British Journal of Cancer and Lancet Oncology. His clinical work focuses on the management of patients with gastric, oesophageal, colorectal, pancreatic, liver and biliary tract cancers using chemotherapy, targeted therapy and immunotherapies, and he is the clinical lead for gastro-oesophageal and hepatobiliary cancer at his institution. He also manages patients with cancer of unknown primary and acts as the clinical lead at his hospital for this.
Areas of interest
colorectal cancer; gastric cancer; neuroendocrine cancer; hepatocellular cancer; oesophageal cancer; pancreatic cancer; liver cancer; cholangiocarcinoma; bile duct cancer; cancer of unknown primary; clinical trials; immunotherapy; molecular genetic profiling.
Medical secretaries
- Hannah Stockwell
- The Leaders in Oncology Care 95 Harley Street London W1G 6AF
- 020 7317 2561
- Hannah.stockwell@hcahealthcare.co.uk
Information for healthcare professionals (Bupa patients only, last 12 months)
-
X0002
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-14 days - (>50)
Wellington Hospital (1-5) Harley Street Clinic (5-50) London Clinic (1-5)
-
X0003
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (>50)
Wellington Hospital (5-50)
-
X0004
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (>50)
Wellington Hospital (1-5)
-
AA844
Clinical supervision and planning for delivery of chemotherapy cycle, remote or in the member's home 1-28 days - (5-50)
-
AA842
Clinical supervision and planning for delivery of chemotherapy cycle, remote or in the member's home 1-14 days - (5-50)
-
AA843
Clinical supervision and planning for delivery of chemotherapy cycle, remote or in the member's home 1-21 days - (5-50)
-
XR180
Ultrasound guided drainage of fluid collection - (5-50)
Wellington Hospital (1-5) Harley Street Clinic (1-5)
-
XR630
Percutaneous nephrostomy - (5-50)
Harley Street Clinic (1-5)
-
L9181
Removal of Portacath/Port-a-Cath/Vasoport Unit - (1-5)
Harley Street Clinic (1-5)
-
XR917
Peripherally inserted central venous catheters (PICCs) under x-ray guidance - (1-5)
Wellington Hospital (1-5) Harley Street Clinic (1-5)